SkyAI, Inc.SKYA
Price (close)
$1.88
Market cap
$80.8M
P/E
—
Revenue (TTM)
$174,178
Net income
-$397.5M
Dividend yield
—
1-year total return
-70.4%
Net margin
-228221.0%
Revenue growth
—
Debt / equity
0.02x
What SkyAI, Inc. does.
Technology, Inc. is a medical device sales and distribution enterprise focused on the marketing and distribution of syringe products
and related drug-delivery systems. We previously designed and manufactured a portfolio of conventional and safety syringes for clinical,
pharmaceutical, and specialty applications and continues to market certain remaining inventory to hospitals, clinics, healthcare providers,
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | $204,120 |
| Net income | — | -$4.7M | -$4.6M | -$9.8M | -$9.3M | -$282.5M |
| Free cash flow | — | -$5.4M | -$7.0M | -$9.2M | -$4.5M | — |
More on SKYA.
- SkyAI, Inc. summary
- SkyAI, Inc. financial statements
- SkyAI, Inc. key metrics
- SkyAI, Inc. health scores and style box
- SkyAI, Inc. earnings
- SkyAI, Inc. dividends
- SkyAI, Inc. valuation
- SkyAI, Inc. ownership and insiders
- SkyAI, Inc. peers
Figures from SkyAI, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.